Cite

HARVARD Citation

    Chan, P. et al. (n.d.). OMRT-14. Small molecule circadian clock compounds exhibit potential as a novel therapy paradigm for glioblastoma. Neuro-oncology advances. p. ii9. [Online]. 
  
Back to record